PfizerXSWX:PFE 59 ROC (Joel Greenblatt) % is 78.82% as of Mar. 2026, which is 18% above its 10-year median of 66.98. GuruFocus rates XSWX:PFE with a GF Score™ of 59/100 and a GF Value™ of CHF21.37 (Fairly Valued). The stock has 5 warning signs investors should review. Among 975 Drug Manufacturers companies, Pfizer ranks better than 86.67% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Pfizer's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 78.82%.
The historical rank and industry rank for Pfizer's ROC (Joel Greenblatt) % or its related term are showing as below:
XSWX:PFE'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 18.56 Med: 66.98 Max: 230.88
Current: 55.91
During the past 13 years, Pfizer's highest ROC (Joel Greenblatt) % was 230.88%. The lowest was 18.56%. And the median was 66.98%.
XSWX:PFE's ROC (Joel Greenblatt) % is ranked better than 86.67% of 975
companies
in the Drug Manufacturers industry
Industry Median: 11.44
vs XSWX:PFE: 55.91
Pfizer's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -17.30% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for Pfizer's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:PFE vs GILD, BMY, AMGN: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - General subindustry, Pfizer's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pfizer ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pfizer's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Pfizer's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 78.82% mean?
Pfizer (XSWX:PFE) has a ROC (Joel Greenblatt) % of 78.82% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pfizer and its competitors. This is 18% above median its historical median of 66.98. Over the past decade, Pfizer's ROC (Joel Greenblatt) % has ranged from 18.56 to 230.88. According to the industry distribution chart, Pfizer ranks #130 out of 975 companies in the Drug Manufacturers industry, placing it in the top 13.3%.
Is Pfizer's ROC (Joel Greenblatt) % too high?
Pfizer's current ROC (Joel Greenblatt) % of 78.82% is 18% above median its 10-year median of 66.98. Over the past 10 years, this metric has ranged from a low of 18.56 to a high of 230.88. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.44. Pfizer's value of 78.82% is 589% above this industry median. Based on the distribution chart, Pfizer ranks #130 out of 975 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pfizer has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's ROC (Joel Greenblatt) % compare to GILD and BMY?
According to the Drug Manufacturers industry distribution chart, Pfizer ranks #130 out of 975 companies for ROC (Joel Greenblatt) %. This places Pfizer in the top 13% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 11.44. Pfizer's value of 78.82% is 589% above this benchmark. Historically, Pfizer's own ROC (Joel Greenblatt) % has ranged from 18.56 to 230.88 over the past decade. While the company's 10-year median is 66.98 vs. the industry median of 11.44, Pfizer has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.44, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pfizer's current ROC (Joel Greenblatt) % of 78.82% is 589% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pfizer and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pfizer's current ROC (Joel Greenblatt) % is 78.82%, which is 18% above median its own 10-year median of 66.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (XSWX:PFE) is currently considered Fairly Valued. The stock's GF Value™ is CHF21.37, compared to a current price of CHF19.98 — trading 6.5% below its estimated fair value. The current ROC (Joel Greenblatt) % is 78.82%, which is 18% above median its 10-year median of 66.98 and 589% above the Drug Manufacturers industry median of 11.44. Pfizer's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Pfizer (XSWX:PFE), the current ROC (Joel Greenblatt) % is 78.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pfizer (XSWX:PFE) Overvalued in 2026?
Based on GuruFocus' analysis, Pfizer stock appears to be undervalued.
The current stock price of CHF19.98 is trading 6.5% below its estimated GF Value™ of CHF21.37.
GuruFocus considers Pfizer to be Fairly Valued.
Key valuation signals for XSWX:PFE:
ROC (Joel Greenblatt) %: 78.82% (18% above median its 10-year median of 66.98)
GF Value™: CHF21.37 vs. price of CHF19.98 (6.5% below fair value)
Industry Position: 589% above the Drug Manufacturers median (#130 of 975)
No single metric tells the full story. See the XSWX:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
59GF Score
Get the complete analysis for XSWX:PFE
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:PFE has been successfully added to your 
